Inflammatory disease biotech Kiniksa Pharmaceuticals files for a $100 million IPO

Spread the love

Inflammatory disease biotech Kiniksa Pharmaceuticals files for a $100 million IPO

http://ipoempire.com/2018/04/29/inflammatory-disease-biotech-kiniksa-pharmaceuticals-files-for-a-100-million-ipo/
— Read on ipoempire.com/2018/04/29/inflammatory-disease-biotech-kiniksa-pharmaceuticals-files-for-a-100-million-ipo/

Leave a Reply